Alcanza Clinical Research Acquires Charlottesville Medical Research
September 6, 2022
Alcanza Clinical Research has acquired Charlottesville Medical Research, adding the Charlottesville, Virginia community-based clinical research site to its integrated investigator site network. The deal expands Alcanza’s geographic reach and inclusive research capabilities to improve access to Phase II-IV trials for under-represented patient populations.
- Buyers
- Alcanza Clinical Research
- Targets
- Charlottesville Medical Research
- Industry
- Healthcare Services
- Location
- Virginia, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Alcanza Clinical Research Acquires Innovation Medical Research Center
April 9, 2024
Healthcare Services
Alcanza Clinical Research, a portfolio company of Martis Capital, has acquired Innovation Medical Research Center, a multi-specialty clinical research site located in Palmetto Bay, Florida. The add-on expands Alcanza’s therapeutic-area capabilities and patient diversity across its investigator site network as part of an ongoing roll-up strategy.
-
Alcanza Clinical Research Acquires FDI Clinical Research
April 22, 2024
Healthcare Services
Alcanza Clinical Research has acquired FDI Clinical Research, a multi-specialty clinical research site based in San Juan with an additional site in Mayagüez, Puerto Rico. The acquisition expands Alcanza’s investigator site network into Puerto Rico, adding Phase I capability and broader therapeutic coverage to reach more diverse patient populations for sponsors and CROs.
-
Alcanza Clinical Research Acquires Accel Research Sites Network
July 18, 2023
Healthcare Services
Alcanza Clinical Research has acquired Accel Research Sites Network, a Florida-headquartered multi-specialty clinical research site network with 22 locations across the Southeast U.S. Accel's operations will be integrated into Alcanza's centralized platform while retaining its brand, expanding Alcanza's geographic footprint, therapeutic capabilities, and access to diverse patient populations.
-
Alcanza Clinical Research Acquires Kansas City Research Institute
May 1, 2024
Healthcare Services
Alcanza Clinical Research, an integrated investigator site network, has acquired Kansas City Research Institute (KCRI), a Phase II–IV clinical research site based in Kansas City, Missouri. The acquisition expands Alcanza's Midwest footprint and therapeutic capabilities in gastroenterology, hepatology and metabolic diseases while increasing trial access for underrepresented patient populations.
-
Martis Capital Invests in Alcanza Clinical Research
October 3, 2022
Healthcare Services
Martis Capital, a middle‑market healthcare private equity firm, announced an investment in Alcanza Clinical Research, a clinical research site network platform founded in December 2021. Martis will support Alcanza's national expansion and capability build‑out — Alcanza has already consolidated five clinical research sites across multiple states and will pursue additional acquisitions and strategic partnerships to scale Phase I–IV capabilities.
-
Alcanza Clinical Research Acquires North Georgia Clinical Research
June 3, 2024
Healthcare Services
Alcanza Clinical Research has acquired North Georgia Clinical Research (NGCR), an investigator site based in Woodstock, Georgia. The acquisition expands Alcanza's investigator-site network in the Atlanta metro and rural Georgia areas to improve patient access and diversity for biopharmaceutical clinical trials.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.